← Back to Search
Noninvasive Detection Of Clinically Occult Lymph-node Metastases In Prostate Cancer.
M. Harisinghani, J. Barentsz, P. Hahn, W. Deserno, S. Tabatabaei, Christine Hulsbergen van de Kaa, J. de la Rosette, R. Weissleder
Published 2003 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
BACKGROUND Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, which gain access to lymph nodes by means of interstitial-lymphatic fluid transport, could be used in conjunction with high-resolution magnetic resonance imaging (MRI) to reveal small nodal metastases. METHODS Eighty patients with presurgical clinical stage T1, T2, or T3 prostate cancer who underwent surgical lymph-node resection or biopsy were enrolled. All patients were examined by MRI before and 24 hours after the intravenous administration of lymphotropic superparamagnetic nanoparticles (2.6 mg of iron per kilogram of body weight). The imaging results were correlated with histopathological findings. RESULTS Of the 334 lymph nodes that underwent resection or biopsy, 63 (18.9 percent) from 33 patients (41 percent) had histopathologically detected metastases. Of these 63 nodes, 45 (71.4 percent) did not fulfill the usual imaging criteria for malignancy. MRI with lymphotropic superparamagnetic nanoparticles correctly identified all patients with nodal metastases, and a node-by-node analysis had a significantly higher sensitivity than conventional MRI (90.5 percent vs. 35.4 percent, P<0.001) or nomograms. CONCLUSIONS High-resolution MRI with magnetic nanoparticles allows the detection of small and otherwise undetectable lymph-node metastases in patients with prostate cancer.
This paper references
Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging.
H. Hricak (1987)
Detection of lymph node metastases by contrast‐enhanced MRI in an experimental model
P. Wunderbaldinger (2002)
The measurement of observer agreement for categorical data.
J. Landis (1977)
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
M. Smith (2001)
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits
S. Ruehm (2001)
Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties
T. Shen (1993)
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
P. Walsh (2000)
Vari - ations in morbidity after radical prostatectomy
T Shen (2002)
MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
M. Harisinghani (1999)
Bilateral Orchiectomy With or Without Flutamide for Metastatic Prostate Cancer
M. Eisenberger (1999)
Axillary lymph node metastases: A statistical analysis of various parameters in MRI with USPIO
C. Stets (2002)
Incidence, Location, and Significance of Periprostatic and Periseminal Vesicle Lymph Nodes in Prostate Cancer
P. S. Kothari (2001)
Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
S. C. Michel (2002)
Advances in biomedical imaging.
C. Tempany (2001)
Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging
C. Corot (2004)
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
Visualization of prostate cancer with 11C-choline positron emission tomography.
I. D. de Jong (2002)
In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI
R. Trivedi (2004)
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
R. Weissleder (1990)
In vivo magnetic resonance imaging of transgene expression
R. Weissleder (2000)
[Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin].
B. Chauvet (1998)
Magnetic relaxation switches capable of sensing molecular interactions
J. M. Pérez (2002)
MR imaging of mediastinal lymph nodes: Evaluation using a superparamagnetic contrast agent
H. Pannu (2000)
Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.
Y. Anzai (1994)
Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic lymphadenectomy compared with nomogram prediction of metastasis.
R. Beissner (2002)
The prostate: MR imaging and spectroscopy. Present and future.
J. Kurhanewicz (2000)
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.
H. Barnett (1991)
Variations in morbidity after radical prostatectomy.
C. Begg (2002)
Prostate cancer schemes for androgen escape
Albert O. Brinkmann (2000)
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
A. Partin (1997)
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
H. Stary (1995)
Open pelvic lymph node dissection for prostate cancer: a reassessment.
S. Campbell (1995)
Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging
C. Billotey (2003)
Imaging macrophage activity in the brain by using ultrasmall particles of iron oxide.
J. Bulte (2000)
Indications for pelvic lymphadenectomy in prostate cancer.
R. Link (2001)
ROC Methodology in Radiologic Imaging
C. Metz (1986)
MRI-guided diagnosis and treatment of prostate cancer.
A. D'Amico (2001)
Cancer volume of lymph node metastasis predicts progression in prostate cancer.
L. Cheng (1998)
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
P. Walsh (2003)
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
L. Holmberg (2002)
Surgery and the reduction of mortality from prostate cancer.
P. Walsh (2002)
Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.
G. Jager (1996)
Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.
R. Katz-Brull (2002)
Cancer Statistics, 2001
R. Greenlee (2001)
This paper is referenced by
Theranostic Metallic Nanomedicine in Oncology: New Insights and Concerns
S. Akhter (2014)
Nanoparticles with CD44 Targeting and ROS Triggering Properties as Effective in Vivo Antigen Delivery System.
X. Liang (2018)
Molecular genetic predictors of prostate cancer progression after radical prostatectomy.
S. Bott (2006)
Lymphknotenmetastasendiagnostik bei urologischen Tumoren
M. Seitz (2010)
MR molecular imaging of angiogenesis using targeted perfluorocarbon nanoparticles.
S. Caruthers (2010)
MR techniques for in vivo molecular and cellular imaging.
E. Delikatny (2005)
Molecular imaging in cardiovascular disease: targets and opportunities
S. Shaw (2009)
Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
P. Pandharipande (2009)
Decontamination of surfaces exposed to single wall carbon nanohorns
Z. Karimia (2016)
RNA Nanodrug Image-Guided Breast Tumor Therapy Using a Small Interfering
M. Kumar (2010)
Strategies for Image-Guided Therapy, Surgery, and Drug Delivery Using Photoacoustic Imaging
Colman Moore (2019)
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
M. Souvatzoglou (2011)
Experimental models to study lymphatic and blood vascular metastasis
L. Chen (2011)
Role of Preoperative Local and Distant Staging in Rectal Cancer
S. M. Engelen (2007)
Conception et synthese de nouvelles sondes ciblees pour l'imagerie moleculaire
Claire Beauvineau (2011)
Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers.
M. Saksena (2006)
Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
S. Heijmink (2007)
THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY: A PILOT STUDY
E. Neuwelt (2007)
Is 11C-choline the most appropriate tracer for prostate cancer?
F. Fazio (2004)
New technologies and directed agents for applications of cancer imaging.
M. Atri (2006)
Technology Insight: monoclonal antibody imaging of prostate cancer
N. Bander (2006)
The role of magnetic resonance imaging in the detection of prostate cancer.
Seungtaek Choi (2011)
Emerging lymphatic imaging technologies for mouse and man.
E. Sevick-Muraca (2014)
Magnetic Nano-Systems in Drug Delivery and Biomedical Applications
Saritha Shetty (2018)
In Vitro Characterization of Magnetic Resonance Imaging Contrast Agents for Molecular Imaging.
Z. Yu (2006)
Extended robotic salvage lymphadenectomy in patients with ‘node-only’ prostate cancer recurrence: initial experience
K. Kolontarev (2018)
Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 2018-2019.
T. Pisansky (2019)
[First results of PET / CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy].
A. Winter (2009)
International Journal of Nanomedicine
Mitsuhiro Terakawa ()
Magnetic Resonance Imaging of the Prostate Gland
Saroja Adusumilli (2006)
Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer
T. Noji (2008)
Magnetic Resonance Imaging in the management of prostate cancer: What the Radiologists need to know?
Sneha Deshpande (2014)See more